- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/133 - Amines, e.g. amantadine having hydroxy groups, e.g. sphingosine
Patent holdings for IPC class A61K 31/133
Total number of patents in this class: 564
10-year publication summary
|
45
|
39
|
44
|
50
|
55
|
53
|
49
|
52
|
28
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Insmed Incorporated | 245 |
17 |
| NeuroDerm, Ltd. | 139 |
11 |
| The Cleveland Clinic Foundation | 1572 |
10 |
| The Regents of the University of California | 20230 |
9 |
| Dyve Biosciences, Inc. | 33 |
9 |
| OCuSOFT, Inc. | 156 |
6 |
| University of Virginia Patent Foundation | 1598 |
6 |
| The Johns Hopkins University | 5739 |
5 |
| Ortho-nutra, LLC | 14 |
5 |
| Vanda Pharmaceuticals, Inc. | 369 |
5 |
| Metanoi Therapeutics, Inc. | 6 |
5 |
| Adjuvant Holdings Co.,Ltd. | 20 |
5 |
| Conopco, Inc. | 5000 |
4 |
| Janssen Pharmaceutica N.V. | 3349 |
4 |
| University of Florida Research Foundation, Inc. | 4074 |
4 |
| Hikma Pharmaceuticals LLC | 11 |
4 |
| Hovione Scientia Limited | 132 |
4 |
| Orasis Pharmaceuticals Ltd | 29 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2895 |
4 |
| Emerald Health Pharmaceuticals Inc. | 14 |
4 |
| Other owners | 439 |